NATEGLINIDE
Generic: NATEGLINIDE
Rising Pharma HoldingsManufacturer
ORALRoute
NATEGLINIDEActive Substance
2018-06-18Original Approval
NATEGLINIDE is FDA application ANDA205544, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
BLOOD GLUCOSE INCREASED
76 reports
2
DIARRHOEA
65 reports
3
DRUG INEFFECTIVE
65 reports
4
DYSPNOEA
64 reports
5
FATIGUE
58 reports
6
NAUSEA
57 reports
7
RENAL FAILURE
51 reports
8
DEATH
49 reports
9
DECREASED APPETITE
48 reports
10
DIZZINESS
45 reports